Street Capital Inc. (CNSX: STRC.X)
Health Care · Pharmaceuticals · CA
CA$—
— today · — 1Y
Street Capital Inc. (CNSX: STRC.X) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $1.01M.
trading between 0.01 and 0.01.
Tweenvest scores Street Capital Inc. across four factors: quality 29/100. Its strongest factor is quality.
STRC.X price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.01M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.00
- Dividend yield
- —
- Beta (5Y)
- 0.68
- 52-week high
- CA$0.01
- 52-week low
- CA$0.01
- Avg volume (3M)
- —
- Shares outstanding
- 280.45M
- Employees
- —
- Next earnings
- —
About Street Capital Inc.
The Hash Corporation focuses on the production and sale of cannabis-based hashish and other cannabis products in Canada. The company was formerly known as Senternet Phi Gamma Inc. and changed its name to The Hash Corporation in July 2019. The Hash Corporation was incorporated in 1967 and is headquartered in Toronto, Canada.
- ISIN
- CA86326R1064
- Founded
- 1967
- Listed since
- Jun 3, 2021
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.11T | $1,246.93 | -0.67% |
| Johnson & JohnsonNYSE: JNJ | $658.00B | $273.04 | +1.04% |
| Merck & Co., Inc.NYSE: MRK | $371.70B | $150.66 | -1.24% |
| Roche Holding AGSWX: ROP | $368.80B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $300.52B | CHF126.76 | -0.52% |
| AstraZeneca PLCLSE: AZN | $256.25B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $206.64B | Dkr299.25 | -0.53% |
| Pfizer Inc.NYSE: PFE | $159.42B | $27.97 | -0.36% |
Figures last refreshed Aug 18, 2026.